Minimus Spine is developing ozone injection technology —TrioJection syringe cartridge — for the treatment of spinal disorders related to herniated discs. The company will use the TETF award for the commercialization of the technology. The company is working with Texas A&M University in College Station on the technology, according to the report.
More Articles on Spine:
Robotics in Spine Surgery: Pros, Cons & Whether it Makes Sense to Adopt Today
5 Spine & Neurosurgeons in New Leadership Positions
Bundled Payments for Spine Surgery: What’s On the Horizon
